# Oral Iron for the Management of Iron Deficiency Anemia in SGLT2i-Treated Heart Failure Patients

> **NCT07708025** · PHASE3 · COMPLETED · sponsor: **Universidade do Porto** · enrollment: 55 (actual)

## Conditions studied

- Heart Failure
- Anemia

## Interventions

- **DRUG:** Oral iron supplementation

## Key facts

- **NCT ID:** NCT07708025
- **Lead sponsor:** Universidade do Porto
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-20
- **Primary completion:** 2026-02-26
- **Final completion:** 2026-03-15
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2026-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07708025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07708025, "Oral Iron for the Management of Iron Deficiency Anemia in SGLT2i-Treated Heart Failure Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07708025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*